PACE

PROVIDER BULLETIN

June 3, 2005

 

Eli Lilly and Company

 

Reconsideration of Rebate Participation

 

 

 

 

Eli Lilly and Company  has notified the PACE Program that it will abide by the statutory requirements of the PACE Program’s manufacturer’s rebate mandate.

 

Therefore the Commonwealth will continue to reimburse for Eli Lilly products for PACE, PACENET, CRDP, SPBP, Cystic Fibrosis, Spina Bifida, PKU or MSUD.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PPB-05-013